CD177 and Miyoshi myopathy: Considering that SLAMF3 is a B and T lymphocyte cell surface receptor that is robustly expressed on MM cells, Radhakrishnan and colleagues have generated SLAMF3 chimeric antigen receptor (CAR) T cells that are highly active against MM plasma cells, memory B cells, and MM-propagating cells in vitro and in vivo (142).